Follicle stimulating hormone as a predictor of ovarian response in women undergoing controlled ovarian hyperstimulation for IVF

被引:31
|
作者
Ashrafi, M
Madani, T
Tehranian, AS
Malekzadeh, F
机构
[1] Royan Inst, Dept Endocrinol & Female Infertil, Tehran, Iran
[2] Iran Univ, Akbar Abadi Hosp, Med Sci & Hlth Serv, Tehran, Iran
[3] Azad Univ Islam Med Sci, Tehran, Iran
关键词
controlled ovarian hyperstimulation; follicle stimulating hormone level at day 3; oocyte; in vitro fertilization; poor ovarian response;
D O I
10.1016/j.ijgo.2005.06.017
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the effect of basal follicle stimulating hormone (FHS) level on ovarian response in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Methods: A descriptive and analytic study of 212 cycles of IVF chosen from about 2200 files of women treated at Royan Institute, Tehran, Iran, from 1991 to 1999. Treatment was started with intranasal or subcutaneous buserlin (0.5 cm(3)), on day 21 (long protocol). On day 2 of the next cycle, stimulation with human menopausal gonadotropin (hMG) was initiated. When the number and size of follicles were suitable, human chorionic gonadotropin (hCG) was given intramuscularly for ovulation induction, followed by oocyte retrieval 36 to 40 h later. Embryos were transferred about 48 to 72 h after oocyte retrieval. The women were assigned to 2 groups on the basis of day 3 serum FSH levels (>= 15 IU/mL, group 1 and < 15 IU/mL, group 2). Results: There were statistically significant differences between the 2 groups in number of follicles, number of oocytes retrieved and embryos transferred (lower in group 1), and level of serum luteinizing hormone and number of canceled cycles (higher in group 1). There were no statistical differences in number of ampoules of hMG used or age of patients. Conclusion: Day-3 serum FSH level was a predictor of ovarian response and IVF outcome in this study. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 50 条
  • [21] Effect of urinary versus recombinant follicle-stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulation
    Bar, J
    Orvieto, R
    Lahav, J
    Hod, M
    Kaplan, B
    Fisch, B
    FERTILITY AND STERILITY, 2004, 82 (06) : 1564 - 1569
  • [22] Does supplementation with recombinant luteinizing hormone prevent ovarian hyperstimulation syndrome in down regulated patients undergoing recombinant follicle stimulating hormone multiple follicular stimulation for IVF/ET and reduces cancellation rate for high risk of hyperstimulation?
    Caserta, Donatella
    Lisi, Franco
    Marci, Roberto
    Ciardo, Francesca
    Fazi, Alessandra
    Lisi, Roberta
    Moscarini, Massimo
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (11) : 862 - 866
  • [23] The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, Xiuxian
    Ye, Hongjuan
    Fu, Yonglun
    MEDICINE, 2016, 95 (28)
  • [24] Antral follicle count as a predictor of hyperresponse in controlled ovarian hyperstimulation/intrauterine insemination in unexplained sterility
    Checa, Miguel A.
    Prat, Maria
    Carreras, Ramon
    FERTILITY AND STERILITY, 2010, 94 (03) : 1105 - 1107
  • [25] Acupuncture for "poor ovarian response" of women to controlled ovarian hyperstimulation A protocol for meta-analysis and systematic review
    Wei, Wei
    Liu, Li-Ying
    Chen, Ling
    Su, Meng-Hua
    Hong, Xiao-Juan
    MEDICINE, 2020, 99 (44) : E22868
  • [26] Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
    Mochtar, Monique H.
    Danhof, Nora A.
    Ayeleke, Reuben Olugbenga
    van der Veen, Fulco
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (05):
  • [27] Analysis of controlled ovarian hyperstimulation protocols in women over 35 years old with poor ovarian response: a real-world study
    Duan, Xiaoyan
    Li, Zhan
    Li, Mingming
    Ma, Xing
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [28] Risk of thrombosis in women with cancer undergoing controlled ovarian hyperstimulation for fertility preservation
    Valeria D. Melo
    Olivia Y. Liseth
    Walker M. Schmidt
    Rajiv K. Pruthi
    Ariela L. Marshall
    Chandra C. Shenoy
    Journal of Assisted Reproduction and Genetics, 2022, 39 : 2847 - 2856
  • [29] Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimullerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection
    Arce, Joan-Carles
    Andersen, Anders Nyboe
    Fernandez-Sanchez, Manuel
    Visnova, Hana
    Bosch, Ernesto
    Garcia-Velasco, Juan Antonio
    Barri, Pedro
    de Sutter, Petra
    Klein, Bjarke M.
    Fauser, Bart C. J. M.
    FERTILITY AND STERILITY, 2014, 102 (06) : 1633 - U456
  • [30] Risk of thrombosis in women with cancer undergoing controlled ovarian hyperstimulation for fertility preservation
    Melo, Valeria D.
    Liseth, Olivia Y.
    Schmidt, Walker M.
    Pruthi, Rajiv K.
    Marshall, Ariela L.
    Shenoy, Chandra C.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2022, 39 (12) : 2847 - 2856